期刊文献+

间期荧光原位杂交技术在慢性淋巴细胞白血病检测中的应用 被引量:2

Genomic abnormalities detected by interphase fluorescence in situ hybridization in chronic lymphocytic leukemia
下载PDF
导出
摘要 目的探讨慢性淋巴细胞白血病(CLL)基因组的异常情况及其临床意义。方法对17例初诊CLL患者进行常规细胞遗传学(CC)检测,同时应用着丝粒探针CSP12(12p11.1-12q11.1)和序列特异性探针D13s25(13q14.3)、ATM(11q22.3)、RB1(13q14)、p53(17p13.1)进行间期荧光原位杂交(I-FISH)。比较I-FISH与CC敏感性的差异。结果 CC检测18.75%有核型异常(3/16),1例未见核分裂相;I-FISH检测70.6%患者有基因异常(12/17),p53缺失11.8%(2/17)、ATM缺失5.6%(1/17)、13q-47.1%(8/17),其中包括RB1缺失23.5%(4/17)、D13S25缺失29.4%(5/17),12-三体29.4%(5/17),复杂基因组异常11.8%(2/17)。核型异常与性别、年龄、乳酸脱氢酶(LDH)、β2微球蛋白(β2-MG)及Binet分期无相关性。结论 I-FISH是检测CLL患者基因组异常的有效手段,与CC方法相比可明显提高CLL基因组异常的检出率。 Objective To investigate the correlation between genomic abnormalities in chronic lymphocytic leukemia(CLL). Methods Routine R-banding was performed in 17 cases with CLL as well as five probes for DI3S25(13q14.3), ATM(11q22.3), RBI(13q14), p53(17p13.1), CSPI2(12pl 1.1-12q11.1) were simultaneously used to detect del(13q14.3), del(11q22.3), del(17pl3.1), del(13ql4) and CSP12 by I-FISH. Results Among 17 cases of CLL, on conventional cytogenetics(CC) examination, only 3 cases(17.6%) were found to have chromosomal abnormalities including sole trisomy 12 in 2 cases and 13q- in one case; while on I-FISH, 12 cases (70.6%) were found to have genomie aberrations including del(17pl3.1) in 2 cases, del(llq22.3) in 1 cases, del(13ql3) in 4 cases, del(13q13.4) in 5 cases, trisomy 12 in 5 cases, among them two cases were complex abnormalities. Conclusion I-FISH is a more rapid, accurate and sensitive technique for detection of genomie aberration in CLL than CC.
作者 周剑波
出处 《分子诊断与治疗杂志》 2010年第4期252-256,共5页 Journal of Molecular Diagnostics and Therapy
  • 相关文献

参考文献10

  • 1D(o)hner H,Stingelbauer S,Benner A,et al.Genomic aberrations and survival in chronic lymphocytic leukemia[J].N Engl J Med,2000,343(26):1910-1916.
  • 2Van Bockstaele F,Verhasselt B,Philippé J.Prognostic markers in chronic lymphocytic leukemia:a comprehensive review[J].Blood Rev,2009,23(1):25-47.
  • 3陈书长.慢性淋巴细胞白血病.见:张之南,沈悌,主编.血液病诊断及疗效标准[M].第3版.北京:科学出版社,2007:139-143.
  • 4Anonymous.Chronic lymphocytic leukemia:recommendations for diagnosis,staging,and response criteria[J].Ann Intern Med,1989,110:236-238.
  • 5Schroers R,Griesinger F,Trumper L,et al.Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia[J].Leukemia,2005,19(5):750-758.
  • 6Di Giovanni S,Valentini G,Carducci P,et al.Beta-2-microglobulin is a reliable tumor marker in chronic lymphocytic leukemia[J].Acta Haematol,1989,81(4):181-185.
  • 7Matutes E,Oscier D,Garcia-Marco J.Trisomy 12 defines a group of CLL with atypical morphology:correlation between cytogenetic,clinical and laboratory features in 544 patients[J].Br J Haematol,1996,92(2):382-388.
  • 8Cimmino A,Calin G A,Fabbri M,et al.miR-15 and miR-16 induce apoptosis by targeting BCL2[J].Proc Natl Acad Sci U S A,2005,102(39):13944-13949.
  • 9Dicker F,Herholz H,Schnittger S.The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype[J].Leukemia,2009,23(1):117-124.
  • 10Caballero D,García-Marco J A,Martino R.Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy chain gene and chromosomal abnormalities(11q-and 17p-)[J].Clin Cancer Res,2005,11(21):7757-7763.

同被引文献23

  • 1Zhang S, Yang ZG, Liu X, et al. Tuberculosis vs. chronic lymphocytic leukaemia in mediastinal lymph nodes using computed tomography[J]. Int J Tuberc Lung Dis, 2014, 18(2):211-215.
  • 2Delgado J, Villamor N.Chronic lymphocytic leukemia in young individuals revisited [J]. Haematologica, 2014, 99(1):4-5.
  • 3Kiefer Y, Schulte C, Tiemann M, et al. Chronic lymphocytic leukemia- tssociated chromosomal abnormalities and miRNA deregulation [J].2012, 12(5):21-28.
  • 4Brejcha M, Stoklasov6 M, Brychtov6 Y, et al. Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybri- d ization and conventional cytogenetics after stimulation with CpG oligonucleotides and intcrleukin-2: A prospective analysis [J]. Leuk Res, 2013, 26(13):374.
  • 5Varga Z, Noske A, Rarnaeh C, et al. Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in sire hybridization and immtmohistochemistry in a single institution over 12 years: a quality control study [J]. BMC Cancer, 2013,13(1): 615.
  • 6Wong KF, Siu LL, Wong WS. Double Minutes and MYC Amplificati- on: A Combined May-Grunwald Giemsa and Fluorescence In Situ Hybridization Study[J]. Am J Clin Pathol, 2014, 141(2):280-284.
  • 7EI-Taweel M, Barin C, Cymbalista F, et al. Detection of chromosom- al abnormalities associated with chronic lymphocytic leukemia: what is the best method [J]. Cancer Genet Cytogenet, 2009, 195(1): 37-42.
  • 8Orlandi EM, Bemasconi P, Pascutto C, et al. Chronic lymphocytic leukemia with dell 3q14 as the sole abnormality: dynamic prognostic estimate by intcrphasc-FISH[J]. Hcmatol Oncol, 2012,31 (3): 136-142.
  • 9Wu S J, Lin CT, Huang SY, et al. Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybrid/- zation inchronie lymphocytic leukemia in Taiwan, an area with low incidence-clinical implication and comparison between the West and the East[J]. Ann Hematoi, 2013, 92(6): 799-806.
  • 10Teimori H, Ashoori S, Akbari MT, et al. FISH Analysis for del6q21 and de117p13 in B-cell Chronic Lymphocytic Leukemia in Iranians [J]. Iron Red Crescent Med J, 2013, 15(2):107-112.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部